25-Hydroxyvitamin D2 /D3 levels and factors associated with systemic inflammation and melanoma survival in the Leeds Melanoma Cohort.
about
Vitamin D, vitamin A, the primary melanoma transcriptome and survivalThe impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysisImmunohistochemical evaluation of vitamin D receptor (VDR) expression in cutaneous melanoma tissues and four VDR gene polymorphisms.Vitamin D deficiency is associated with a worse prognosis in metastatic melanoma.Noncalcemic 20-hydroxyvitamin D3 inhibits human melanoma growth in in vitro and in vivo modelsOn the role of classical and novel forms of vitamin D in melanoma progression and management.Prognostic Value of 25-hydroxyvitamin D3 Levels at Diagnosis and During Follow-up in Melanoma Patients.BsmI (rs1544410) and FokI (rs2228570) vitamin D receptor polymorphisms, smoking, and body mass index as risk factors of cutaneous malignant melanoma in northeast Italy.Vitamin D as an adjuvant in melanoma therapy.Clustering of prevention behaviours in patients with high-risk primary melanoma.Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management.The interaction between vitamin D receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival.Vitamin D and the Skin: An Update for Dermatologists.β-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomas.
P2860
Q28078120-A4FD427D-22F3-48D4-96C6-D116E0F95604Q33577607-6ED3CD97-1B85-4082-A372-390B7912FF81Q33728928-A6289BD7-E4C1-43B4-998A-5D4D44294C5AQ37701695-425C0A26-D8D8-46D3-9164-BF746566160FQ37706071-427ACDC7-4C13-4AED-82FB-9F8DC93280B1Q38662850-64C13C52-C96A-4B45-AFED-59DAA2BDA633Q41351502-3B5CEB82-2E14-4F4D-A71C-6CD338A5C0C8Q41514239-AC24B592-0728-4400-91E9-AB81FAB9B5F3Q41548479-CC7B1C0B-92CE-4550-9E08-260CAFB2308BQ47890779-8E59D27D-B6C3-4A34-AB2C-E19C0D016CC5Q48218051-C227EE4A-C72D-47B4-AC06-4D428391CCA8Q48224142-BD51270B-7F7E-4316-B344-2ADD2F70C4B8Q49374967-9A2CC71C-CEB3-4C4E-BD15-511A1ED76A48Q52801913-09736C86-4773-47DA-8CB7-FA970374EAED
P2860
25-Hydroxyvitamin D2 /D3 levels and factors associated with systemic inflammation and melanoma survival in the Leeds Melanoma Cohort.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
25-Hydroxyvitamin D2 /D3 level ...... in the Leeds Melanoma Cohort.
@ast
25-Hydroxyvitamin D2 /D3 level ...... in the Leeds Melanoma Cohort.
@en
25-Hydroxyvitamin D2 /D3 level ...... in the Leeds Melanoma Cohort.
@en-gb
type
label
25-Hydroxyvitamin D2 /D3 level ...... in the Leeds Melanoma Cohort.
@ast
25-Hydroxyvitamin D2 /D3 level ...... in the Leeds Melanoma Cohort.
@en
25-Hydroxyvitamin D2 /D3 level ...... in the Leeds Melanoma Cohort.
@en-gb
prefLabel
25-Hydroxyvitamin D2 /D3 level ...... in the Leeds Melanoma Cohort.
@ast
25-Hydroxyvitamin D2 /D3 level ...... in the Leeds Melanoma Cohort.
@en
25-Hydroxyvitamin D2 /D3 level ...... in the Leeds Melanoma Cohort.
@en-gb
P2093
P2860
P50
P356
P1476
25-Hydroxyvitamin D2 /D3 level ...... l in the Leeds Melanoma Cohort
@en
P2093
Charles O'Donovan
Faheem Latheef
Jo Gascoyne
John R Davies
Saila Waseem
Susan Haynes
P2860
P304
P356
10.1002/IJC.29334
P577
2014-12-13T00:00:00Z